VANCOUVER, BC / ACCESSWIRE / February 11, 2019 / Viridium Pacific Group Ltd. ("Viridium") (TSXV: VIR) (OTCPink: VIRFF) wishes to advise, upon inquiry by Viridium, the TSX Venture Exchange has confirmed that the trading halt imposed on Viridium's common shares will be lifted at market open on Wednesday, February 13, 2019 (not February 11, 2019 as originally conveyed). The trading halt was a requirement by the TSX Venture Exchange in connection with Viridium's proposed acquisition of EFX Laboratories Inc. which was completed today.
About Viridium
Viridium Pacific Group Ltd. is a consumer wellness, medical and biotech innovation company based in British Columbia, and the parent company of operating subsidiaries involved in horticultural production, (Experion Biotechologies Inc.), medical product production (EFX Labs) property development (Fish Trap Ventures Ltd.), and human resource management (Stave Lake Services Ltd.). Experion Biotechnologies Inc., is a Health Canada licensed producer of cannabis, which operates in an 8,300 square-foot indoor facility outside of Mission, BC.
More information about Viridium can be found under the Company's profile on SEDAR at www.sedar.com.
For further information:
www.viridiumpacific.com
Jarrett Malnarick,
Info@viridiumpacific.com
604 837 8688
SOURCE: Viridium Pacific Group Ltd.
View source version on accesswire.com:
https://www.accesswire.com/535027/Viridium-to-Resume-Trading-February-13-2019
